Administration for Strategic Preparedness and Response
Washington D.C.hhs.gov
Overview
The Administration for Strategic Preparedness and Response is a U.S. government agency that leads the nation in preparing for, responding to, and recovering from public health emergencies and disasters through grants and funding for medical countermeasures and other technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NeuImmune, Inc. | Dec 2025 | Corporate Funding | Co-investor |
| Amplitude Therapeutics | Aug 2024 | Grant | Co-investor |
| Capra Biosciences | Jul 2024 | Grant | Co-investor |
| Maxim Biomedical | Jan 2024 | Grant | Co-investor |
| Eradivir | Sep 2023 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
